SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex formation between a vesicle and the target membrane is a central aspect of probably all vesicle fusion reactions. The sec1/munc18 (SM) protein family is also involved in membrane trafficking and fusion events. However, in contrast with the consensus on SNARE protein function, analysis of SM proteins in different systems has produced different ideas about their exact role, their site of action and their relationship to SNARE proteins. Deletion of the SM protein involved in secretory vesicle release in mice, Munc18-1, results in a complete block of exocytosis. Manipulation of Munc18-1 protein levels in neurons and adrenal chromaffin cells argues for a positive role of this protein in vesicle secretion, as overexpression results in an increase in vesicle secretion. A decrease in Munc18-1 protein levels, on the other hand, leads to a decrease in vesicle secretion.
Introduction
Secretory vesicle exocytosis is a highly dynamic process that is spatially and temporally regulated via a cascade of protein-protein interactions [1] [2] [3] . SNARE (soluble Nethylmaleimide-sensitive factor attachment protein receptor) protein complex formation is likely to drive the fusion of secretory vesicles [4] , but does not account for the tethering/docking of these vesicles at their target and is not sufficient to guarantee spatial specificity or to meet temporal requirements [5] . Therefore additional proteins that control, or even function independently of, SNARE complexes need to provide the molecular mechanisms that ensure functional calcium-dependent vesicle exocytosis (for reviews, see [2, 6] ).
The sec1/munc18 (SM) protein family is also involved in all membrane trafficking events and is essential for regulated exocytosis, as null mutations in SM genes in a wide variety of species result in a loss of vesicle fusion reactions (for a review, see [7] ). Deletion of Munc18-1, the murine SM gene, shows that Munc18-1 is required for synaptic vesicle release in both the central and peripheral nervous systems [8] , and that Munc18-1 is an important component of large dense-core vesicle (LDCV) release from adrenal chromaffin cells. Importantly, deletion of Munc18-1 results in a 10-fold decrease in docked LDCVs [9] . This review summarizes our findings on manipulating Munc18-1 expression levels in mice, and discusses the importance of the interaction of Munc18-1 with its binding partner syntaxin 1.
Key words: exocytosis, Munc18-1, sec1/munc18 family, SNARE complex, syntaxin 1, vesicle secretion. Abbreviations used: E18, embryonic day 18; LDCV, large dense-core vesicle; SM, sec1/munc18; SNARE, soluble N-ethylmaleimide-sensitive factor attachment protein receptor. 1 e-mail ruud@cncr.vu.nl
Munc18-1-null mutant phenotype
Munc18-1 function is essential for the secretion of neurotransmitter-filled synaptic vesicles in mice [8] . Munc18-1-null mutant embryos are completely paralysed and stillborn. Electrophysiological recordings of GABAergic (where GABA is γ -aminobutyric acid) neocortical and cholinergic neuromuscular junction synapses at embryonic day 18 (E18) reveals an absolute lack of neurotransmitter release, although post-synaptic receptors are present and respond normally to ectopically applied neurotransmitter. The analysis of these mice allows us to answer a number of questions concerning the function of Munc18-1 and the effects of a complete lack of neurotransmitter release on synapse formation and maintenance.
First, Munc18-1 is essential for synaptic vesicle release, but not for vesicle transport to and docking at the presynaptic membrane, at least in premature neurons at E18. Electron microscopic analysis of the marginal zone of the cortex of E18 Munc18-1-null mutant mice shows synaptic terminals with synaptic vesicles attached to the membrane. Interestingly, this vesicle docking appears to be non-functional, as docked vesicles are not capable of releasing neurotransmitter in the absence of Munc18-1. In contrast with synaptic vesicle docking at E18, deletion of Munc18-1 does result in a significant reduction of LDCV docking [9] . Although the exact mechanism is not known, this discrepancy may be explained by the presence of an active zone in presynaptic terminals where synaptic vesicles dock and fuse. These specialized structures, which do not seem to be present in chromaffin cells, harbour a set of proteins that might ensure Munc18-1-independent synaptic vesicle docking. One other explanation may be that, in immature synapses, vesicle docking may be regulated in a different, Munc18-1-independent, way than in fully matured and functional synapses.
Secondly, a number of presynaptic proteins appear to depend for their stability on the presence of Munc18-1. The Munc18-1-binding proteins, DOC2A/B (double-c2-containing protein on secretory vesicles) and syntaxin 1, are particularly affected.
Thirdly, the formation of morphologically defined synapses does not require synaptic activity, but, in the absence of neurotransmitter release, connectivity is not maintained. Initially all brain structures develop normally, but they degenerate in order of appearance (i.e. brain structures that develop first also show degeneration first). The neurodegeneration in munc18-1-deficient mice may be the consequence of two different mechanisms. The lack of neurotransmission may result in an inability to maintain synaptic connections (for a review on the importance of neurotransmission for synapse development, see [10] ). This lack of neurotransmission in itself appears not to be enough to trigger apoptosis [11] , but, in combination with impaired secretion of neurotrophic factors containing LDCVs, may induce neuronal apoptosis in Munc18-1-null mutant mice. Alternatively, the Munc18-1 deficiency itself may lead to cellautonomous defects. It has been suggested that the role of the tight interaction with the target (t-) SNARE syntaxin 1 is to protect this protein en route to the presynaptic terminal from engaging in non-cognate protein interactions [12] . Overexpression studies in heterologous cell types point in this direction [13] . However, our analysis of Munc18-1-deficient neurons provides evidence that this is not the case; the morphology of the organelles in the secretory pathway (endoplasmic reticulum and Golgi) is indistinguishable from that in wild-type neurons, and syntaxin 1 transport into axonal projections is possible. However, due to the lower syntaxin 1 proteins levels in Munc18-1-deficient neurons, we have not been able to examine the transport of syntaxin 1 in a quantitative way. It may be that, in the absence of Munc18-1, syntaxin 1 transport to the presynaptic terminal is less efficient.
Munc18-1-overexpression phenotype
Deletion of Munc18-1 orthologues in yeast (SEC1), Caenorhabditis elegans (UNC-18) and Drosophila (ROP) results in similar secretion defects as those observed after deletion of Munc18-1 expression [8, [14] [15] [16] . Furthermore, in both Drosophila and mice, reducing the protein levels of ROP or Munc18-1 results in an almost proportional decrease in neurotransmitter release ( [17] ; R.F.G. Toonen, unpublished work). Hence Munc18-1-like proteins are required and act as rate-limiting factors for vesicular secretion in a variety of organisms.
In contrast with the similar phenotype observed after deletion of a Munc18-1-like protein, overexpression leads to markedly different effects in different organisms. In mice, overexpression of Munc18-1 results in a robust increase in both LDCV and synaptic vesicle secretion ( [9] ; R.F.G. Toonen, unpublished work). In contrast, overexpression of ROP in Drosophila appears to inhibit neurotransmission [18] . One possible explanation is that Munc18-1 may interact with additional or more specialized proteins at the presynaptic terminal. Therefore the whole synaptic machinery in mammals may be more efficient at translating increased protein levels of one of its constituents into enhanced neurotransmission.
Biological relevance of the Munc18-1-syntaxin 1 interaction
Munc18-1 has no apparent membrane-attachment domains and is therefore incapable of interacting directly with membranes. Hence Munc18-1 can only influence vesicle release by linking membrane proteins with proteins present on secretory vesicles. Munc18-1 interacts with DOC2 [19] on the secretory vesicle, and with Mint 1 [20] and syntaxin 1 [21] at the cell membrane. The involvement of syntaxin 1 in vesicle release is undisputed, and the high-affinity interaction between Munc18-1 and syntaxin 1 suggests that the two proteins interact functionally in vivo. However, it appears unlikely that Munc18-1 functions solely via syntaxin 1. As mentioned above, in the absence of Munc18-1 no deleterious effect on syntaxin is observed and recruitment of syntaxin to presynaptic terminals appears normal. Moreover, studies on mutant Munc18 and syntaxin proteins with lowered or no mutual affinity provide evidence for syntaxin-independent roles for Munc18-1 in vesicle secretion [22] [23] [24] [25] . For instance, Munc18-2 mutants with no apparent affinity for syntaxin 3 are still attached to membranes, suggesting that other membrane proteins do interact with Munc18-2 to ensure its membrane localization [22] .
Based on the interaction with the proposed presynaptic proteins neurexin and CASK (calcium/calmodulindependent serine protein kinase) [26] , Mint 1 is an attractive candidate to recruit Munc18-1 to sites of vesicle secretion, and may be one of the proteins that is involved in syntaxinindependent roles for Munc18-1 in vesicle fusion. The most convincing experiments for a syntaxin-independent function of Munc18 have been described in C. elegans. Here, the severe phenotype of a syntaxin-null mutation is rescued by the introduction of a syntaxin mutant that is locked in the 'open' conformation [23] . This remarkable phenotype suggests that the closed conformation of syntaxin is dispensable for neurotransmission. UNC-18 binds to the closed conformation of syntaxin and not (or at least with severely reduced affinity) to the open conformation, implying that the syntaxin-UNC-18 interaction is not necessary for neurotransmission. However, these results must be interpreted with caution, as loss of affinity is always studied in in vitro assays that may not represent the in vivo situation.
In conclusion, although progress has been made in understanding the role of Munc18-1 in vesicle trafficking and release, a number of questions remain. The advent of new technology should help us to resolve some of the remaining questions. Evanescent wave microscopy offers the opportunity to visualize vesicles in real time while en route to the cell membrane [27] . This technique allows us to analyse the role of Munc18-1 in controlling the kinetics of LDCV docking. New mouse models, in particular a model in which Munc18-1 deletion can be controlled spatially and temporally, will be instrumental for investigating a number of different questions. (i) It may reveal whether or not Munc18-1 is involved in synaptic vesicle docking in mature neurons. (ii) Combining the controlled deletion of Munc18-1 with the parallel expression of mutant forms of the protein in the same neuron (i.e. replacing wild-type Munc18-1 with a mutant form) will provide a more mechanistic understanding of the role of Munc18-1 in both LDCV and synaptic vesicle secretion. (iii) This model will allow us to silence connections between specific brain regions, making many invasive deletion experiments redundant. In initial experiments, the connection between cerebellar Purkinje cells and their downstream targets has been interrupted by specifically deleting Munc18-1 only in these Purkinje cells at a postnatal stage (R.F.G. Toonen and R. Hensbroek, unpublished work).
An important area for further investigation will be to understand if, how and when Munc18-1 is released from syntaxin 1, and how and when it rebinds if it ever detaches completely from syntaxin. Using fluorescence resonance energy transfer ('FRET') technology [28] , with which protein interactions can be studied in real time in (for instance) hippocampal slices or chromaffin cells, we may be able to gain insight into this mechanism. Finally, we need to (re-)examine interactions with additional proteins that are involved in Munc18-1-dependent vesicle secretion. Munc18-1 is present in the presynaptic 'particle web', the presynaptic equivalent of the post-synaptic density [29] , but it does not specifically localize at the active zone, and therefore other proteins may be necessary for Munc18-1 to act at this site.
